HSPGX
Price
$33.90
Change
+$0.53 (+1.59%)
Updated
Jun 2 closing price
Net Assets
1.49B
WCMNX
Price
$14.98
Change
+$0.18 (+1.22%)
Updated
Jun 2 closing price
Net Assets
53.09M
Interact to see
Advertisement

HSPGX vs WCMNX

Header iconHSPGX vs WCMNX Comparison
Open Charts HSPGX vs WCMNXBanner chart's image
HSPGX vs WCMNX Comparison Chart in %
View a ticker or compare two or three
VS
HSPGX vs. WCMNX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSPGX is a Buy and WCMNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HSPGX has more cash in the bank: 1.49B vs. WCMNX (53.1M). HSPGX (0.00) and WCMNX (0.00) have matching dividends . HSPGX was incepted earlier than WCMNX: HSPGX (34 years) vs WCMNX (7 years). WCMNX (2.04) is less costly to investors than HSPGX (1.04). WCMNX is a more actively managed with annual turnover of: 89.00 vs. HSPGX (45.00). WCMNX has a lower initial minimum investment than HSPGX: WCMNX (1000) vs HSPGX (2000). HSPGX annual gain was more profitable for investors over the last year : 47.85 vs. WCMNX (25.42). HSPGX return over 5 years is better than : -1.33 vs. WCMNX (-1.40).
HSPGXWCMNXHSPGX / WCMNX
Total Expense Ratio1.021.2482%
Annual Report Gross Expense Ratio1.042.0451%
Fund Existence34 years7 years-
Gain YTD24.0529.225261%
Front Load5%N/A-
Min. Initial Investment20001000200%
Min. Initial Investment IRAN/AN/A-
Net Assets1.49B53.1M2,800%
Annual Yield % from dividends0.000.00-
Returns for 1 year47.8525.42188%
Returns for 3 years55.4331.21178%
Returns for 5 years-1.33-1.4095%
Returns for 10 years87.86N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RERBX63.02N/A
N/A
American Funds EUPAC R2
GOGFX45.07N/A
N/A
Victory Sycamore Small Company Opp R
SGQAX48.41N/A
N/A
DWS International Opportunities A
PHLQX46.73N/A
N/A
PGIM Jennison Health Sciences R6
DLQIX15.32N/A
N/A
BNY Mellon Large Cap Equity I